{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T12:14:45Z","timestamp":1778328885006,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Support Committee"},{"name":"International Vaccine Institute","award":["CHMTD05083-010"],"award-info":[{"award-number":["CHMTD05083-010"]}]},{"DOI":"10.13039\/501100017634","name":"LG Electronics","doi-asserted-by":"publisher","award":["CHMTD05083-020"],"award-info":[{"award-number":["CHMTD05083-020"]}],"id":[{"id":"10.13039\/501100017634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021024","name":"Community Chest of Korea","doi-asserted-by":"publisher","award":["CHMTD05083-030"],"award-info":[{"award-number":["CHMTD05083-030"]}],"id":[{"id":"10.13039\/100021024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Government of Republic of Korea"},{"DOI":"10.13039\/100004441","name":"Swedish International Development Cooperation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cholera outbreaks in Ethiopia necessitate frequent mass oral cholera vaccine (OCV) campaigns. Despite this, there is a notable absence of a comprehensive summary of these campaigns. Understanding national OCV vaccination history is essential to design appropriate and effective cholera control strategies. Here, we aimed to retrospectively review all OCV vaccination campaigns conducted across Ethiopia between 2019 and 2023.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The OCV request records from 2019 to October 2023 and vaccination campaign reports for the period from 2019 to December 2023 were retrospectively accessed from the Ethiopia Public Health Institute (EPHI) database. Descriptive analysis was conducted using the retrospective data collected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From 2019 to October 2023, Ethiopian government requested 32 044 576 OCV doses (31 899 576 doses to global stockpile; 145 000 doses to outside of stockpile). Around 66.3% of requested doses were approved; of which 90.4% were received. Fifteen OCV campaigns (12 reactive and 3 pre-emptive) were conducted, including five two-dose campaigns with varying dose intervals and single-dose campaigns partially in 2019 and entirely in 2021, 2022 and 2023. Overall vaccine administrative coverage was high; except for Tigray region (41.8% in the 1st round; 2nd round didn't occur). The vaccine administrative coverage records were documented, but no OCV coverage survey data was available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study represents the first comprehensive review of OCV campaigns in Ethiopia spanning the last five years. Its findings offer valuable insights into informing future cholera control strategies, underscoring the importance of monitoring and evaluation despite resource constraints. Addressing the limitations in coverage survey data availability is crucial for enhancing the efficacy of future campaigns.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae194","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T16:54:58Z","timestamp":1720803298000},"page":"S20-S32","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023"],"prefix":"10.1093","volume":"79","author":[{"given":"Moti","family":"Edosa","sequence":"first","affiliation":[{"name":"Public Health Emergency Management, Ethiopia Public Health Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1728-3627","authenticated-orcid":false,"given":"Yeonji","family":"Jeon","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Gedefaw","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"},{"name":"College of Medicine and Health Sciences, Hawassa University , Hawassa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejene","family":"Hailu","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"},{"name":"School of Public Health, Hawassa University , Hawassa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edlawit","family":"Mesfin Getachew","sequence":"additional","affiliation":[{"name":"Clinical Trials Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondari D","family":"Mogeni","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun Hyeog","family":"Jang","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management (BDM) Department, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mukasa","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management (BDM) Department, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biruk","family":"Yeshitela","sequence":"additional","affiliation":[{"name":"Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Getahun","sequence":"additional","affiliation":[{"name":"Clinical Trials Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Lynch","sequence":"additional","affiliation":[{"name":"Cholera Program Director, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika","family":"Bouhenia","sequence":"additional","affiliation":[{"name":"Global Task Force on Cholera Control (GTFCC), World Health Organization (WHO) , Geneva , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeshambel","family":"Worku Demlie","sequence":"additional","affiliation":[{"name":"Public Health Emergency Management, Ethiopia Public Health Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukemil","family":"Hussen","sequence":"additional","affiliation":[{"name":"Public Health Emergency Management, Ethiopia Public Health Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesfin","family":"Wossen","sequence":"additional","affiliation":[{"name":"Public Health Emergency Management, Ethiopia Public Health Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mekonnen","family":"Teferi","sequence":"additional","affiliation":[{"name":"Clinical Trials Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1632-3045","authenticated-orcid":false,"given":"Se Eun","family":"Park","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"},{"name":"Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"2024071515061047400_ciae194-B1","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1080\/21645515.2018.1504155","article-title":"Oral cholera vaccines and their impact on the global burden of disease","volume":"15","author":"Wierzba","year":"2019","journal-title":"Hum Vacci Immunother"},{"key":"2024071515061047400_ciae194-B2","author":"World Health Organization"},{"key":"2024071515061047400_ciae194-B3","author":"Global Task Force on Cholera Control"},{"key":"2024071515061047400_ciae194-B4","author":"GTFCC OCV Working Group Annual Meeting"},{"key":"2024071515061047400_ciae194-B5","author":"Global Task Force on Cholera Control"},{"key":"2024071515061047400_ciae194-B6","author":"Wosen"},{"key":"2024071515061047400_ciae194-B7","author":"ReliefWeb"},{"key":"2024071515061047400_ciae194-B8","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Global oral cholera vaccine use, 2013\u20132018","volume":"38","author":"Pezzoli","year":"2020","journal-title":"Vaccine"},{"key":"2024071515061047400_ciae194-B9","author":"Global Task Force on Cholera Control"},{"key":"2024071515061047400_ciae194-B10","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1080\/21645515.2021.1977057","article-title":"Vaccines and vaccination: history and emerging issues","volume":"17","author":"Kayser","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2024071515061047400_ciae194-B11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12889-023-15326-2","article-title":"A scoping review of facilitators and barriers influencing the implementation of surveillance and oral cholera vaccine interventions for cholera control in lower- and middle-income countries","volume":"23","author":"Trolle","year":"2023","journal-title":"BMC Public Health"},{"key":"2024071515061047400_ciae194-B12","author":"Global Task Force on Cholera Control"},{"key":"2024071515061047400_ciae194-B13","volume-title":"Clin Infect Dis"},{"key":"2024071515061047400_ciae194-B14"},{"key":"2024071515061047400_ciae194-B15","author":"World Health Organization"},{"key":"2024071515061047400_ciae194-B16","doi-asserted-by":"crossref","first-page":"e1001867","DOI":"10.1371\/journal.pmed.1001867","article-title":"The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study","volume":"12","author":"Azman","year":"2015","journal-title":"PLoS Med"},{"key":"2024071515061047400_ciae194-B17","doi-asserted-by":"crossref","first-page":"e0010358","DOI":"10.1371\/journal.pntd.0010358","article-title":"Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: a modeling study","volume":"16","author":"Leung","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2024071515061047400_ciae194-B18","doi-asserted-by":"crossref","first-page":"e1901","DOI":"10.1371\/journal.pntd.0001901","article-title":"Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau City, Guinea Bissau","volume":"6","author":"Azman","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2024071515061047400_ciae194-B19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024071515061047400_ciae194-B20","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/cid\/cix1039","article-title":"Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis","volume":"66","author":"Lopez","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024071515061047400_ciae194-B21","author":"World Health Organization"},{"key":"2024071515061047400_ciae194-B22","doi-asserted-by":"crossref","first-page":"e0003574","DOI":"10.1371\/journal.pntd.0003574","article-title":"Flexibility of oral cholera vaccine dosing\u2014a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone","volume":"9","author":"Kanungo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2024071515061047400_ciae194-B23","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1016\/j.vaccine.2021.06.034","article-title":"Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia","volume":"39","author":"Mwaba","year":"2021","journal-title":"Vaccine"},{"key":"2024071515061047400_ciae194-B24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.vaccine.2019.12.034","article-title":"Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: revaccination after an interval of over three years of primary vaccination with a single dose of vaccine","volume":"38","author":"Chowdhury","year":"2020","journal-title":"Vaccine"},{"key":"2024071515061047400_ciae194-B25","doi-asserted-by":"crossref","first-page":"e0219040","DOI":"10.1371\/journal.pone.0219040","article-title":"Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: cholera control strategy in Lusaka, 2016","volume":"14","author":"Ferreras","year":"2019","journal-title":"PLoS One"},{"key":"2024071515061047400_ciae194-B26","author":"UNICEF"},{"key":"2024071515061047400_ciae194-B27","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3201\/eid2812.212398","article-title":"Association between conflict and cholera in Nigeria and the Democratic Republic of the Congo","volume":"28","author":"Charnley","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2024071515061047400_ciae194-B28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3855\/jidc.10129","article-title":"Yemen: cholera outbreak and the ongoing armed conflict","volume":"12","author":"Dureab","year":"2018","journal-title":"J Infect Dev Countries"},{"key":"2024071515061047400_ciae194-B29"},{"key":"2024071515061047400_ciae194-B30","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1016\/j.vaccine.2017.10.108","article-title":"Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa: a rapid qualitative assessment","volume":"36","author":"Heyerdahl","year":"2018","journal-title":"Vaccine"},{"key":"2024071515061047400_ciae194-B31","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2016.06.053","article-title":"Monitoring vaccination coverage: defining the role of surveys","volume":"34","author":"Cutts","year":"2016","journal-title":"Vaccine"},{"key":"2024071515061047400_ciae194-B32","doi-asserted-by":"crossref","first-page":"e053585","DOI":"10.1136\/bmjopen-2021-053585","article-title":"Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool","volume":"12","author":"Elias Chitio","year":"2022","journal-title":"BMJ Open"},{"key":"2024071515061047400_ciae194-B33","doi-asserted-by":"crossref","first-page":"1147563","DOI":"10.3389\/fpubh.2023.1147563","article-title":"Oral cholera vaccine coverage evaluation survey: forcibly displaced Myanmar nationals and host community in Cox's bazar, Bangladesh","volume":"11","author":"Qayum","year":"2023","journal-title":"Front Public Health"},{"key":"2024071515061047400_ciae194-B34","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.vaccine.2023.01.026","article-title":"Coverage survey and lessons learned from a pre-emptive cholera vaccination campaign in urban and rural communities affected by landslides and floods in Freetown Sierra Leone","volume":"41","author":"Gelormini","year":"2023","journal-title":"Vaccine"},{"key":"2024071515061047400_ciae194-B35","doi-asserted-by":"crossref","first-page":"e0006652","DOI":"10.1371\/journal.pntd.0006652","article-title":"The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: a disease modeling and economic analysis","volume":"12","author":"Khan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2024071515061047400_ciae194-B36","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S1473-3099(20)30781-7","article-title":"Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial","volume":"21","author":"Ali","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024071515061047400_ciae194-B37","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/vaccines9121482","article-title":"Oral cholera vaccine efficacy and effectiveness","volume":"9","author":"Song","year":"2021","journal-title":"Vaccines"},{"key":"2024071515061047400_ciae194-B38","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/Supplement_1\/S20\/58546138\/ciae194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/Supplement_1\/S20\/58546138\/ciae194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:20:54Z","timestamp":1721060454000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/79\/Supplement_1\/S20\/7712960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":38,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2024,7,12]]},"published-print":{"date-parts":[[2024,7,12]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae194","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7,15]]},"published":{"date-parts":[[2024,7,12]]}}}